Showing results (581-590 of 701) with videos related to
Sort By:
Pageof 71
JACC. Heart Failure|August 27, 2021
Effects of Dapagliflozin in Patients With Kidney Disease, With and Without Heart FailureJohn J V McMurray, David C Wheeler, Bergur V Stefánsson, et al.Journal of the American Society of Nephrology : JASN|July 17, 2021
Effects of Dapagliflozin in Stage 4 Chronic Kidney DiseaseGlenn M Chertow, Priya Vart, Niels Jongs, et al.European Heart Journal|April 1, 2021
Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trialHiddo J L Heerspink, C David Sjöström, Niels Jongs, et al.Journal of the American Society of Nephrology : JASN|April 2, 2026
Association of Urinary Epidermal Growth Factor with Kidney Outcomes and Effects of Sodium-Glucose Cotransporter 2 InhibitionErik Moedt, Akihiko Koshino, Niels Jongs, et al.Journal of Diabetes and Its Complications|October 16, 2018
Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney diseaseGlenn M Chertow, Gerald B Appel, Geoffrey A Block, et al.BMJ Open Diabetes Research & Care|April 11, 2024
Circulating metabolomic markers in association with overall burden of microvascular complications in type 1 diabetesViktor Rotbain Curovic, Brede A Sørland, Tine W Hansen, et al.The Lancet. Planetary Health|April 5, 2024
Ambient heat exposure and kidney function in patients with chronic kidney disease: a post-hoc analysis of the DAPA-CKD trialZhiyan Zhang, Hiddo J L Heerspink, Glenn M Chertow, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 2, 2009
Development and validation of GFR-estimating equations using diabetes, transplant and weightLesley A Stevens, Christopher H Schmid, Yaping L Zhang, et al.Clinical Kidney Journal|March 3, 2023
A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney diseaseRajiv Agarwal, Bertram Pitt, Biff F Palmer, et al.NEJM Evidence|February 6, 2024
Dapagliflozin and Anemia in Patients with Chronic Kidney DiseaseAkihiko Koshino, Meir Schechter, Glenn M Chertow, et al.Pageof 71